Nuzenio

Sino Biological

Sino Biological news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Sino Bio's benmelstobart-anlotinib regimen adds new China indication in first-line squamous NSCLC - AllSciAllSci · Fri, 07 Aug 2026 16:21:02 GMT Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development - the-scientist.comthe-scientist.com · Tue, 04 Aug 2026 18:48:18 GMT Sino Biological launches precisely characterised full-length p-Tau217 protein - Scientist LiveScientist Live · Mon, 03 Aug 2026 13:08:38 GMT Breaking the Wet-Lab Bottleneck in AI-Driven Antibody Discovery - Inside Precision MedicineInside Precision Medicine · Sat, 01 Aug 2026 10:30:21 GMT Enterprise value to EBITDA forward of Sino Biological Inc. Class A – SZSE:301047 - TradingViewTradingView · Sat, 01 Aug 2026 08:14:32 GMT Sino Biological launches SuperNuclease® Pro with free trial program - News-MedicalNews-Medical · Fri, 31 Jul 2026 05:05:00 GMT Sino Biological introduces SuperNuclease Pro with free trial programme - Scientist LiveScientist Live · Thu, 30 Jul 2026 09:30:11 GMT

Timeline

Fri, 07 Aug 2026 16:21:02 GMTSino Bio's benmelstobart-anlotinib regimen adds new China indication in first-line squamous NSCLC - AllSci

Tue, 04 Aug 2026 18:48:18 GMTSino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development - the-scientist.com

Mon, 03 Aug 2026 13:08:38 GMTSino Biological launches precisely characterised full-length p-Tau217 protein - Scientist Live

Sat, 01 Aug 2026 10:30:21 GMTBreaking the Wet-Lab Bottleneck in AI-Driven Antibody Discovery - Inside Precision Medicine

Sat, 01 Aug 2026 08:14:32 GMTEnterprise value to EBITDA forward of Sino Biological Inc. Class A – SZSE:301047 - TradingView

Fri, 31 Jul 2026 05:05:00 GMTSino Biological launches SuperNuclease® Pro with free trial program - News-Medical

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Inside Precision Medicine3 live mentions China2 live mentions Sino Biological Launches2 live mentions Precisely Characterized Full2 live mentions Length2 live mentions Protein2 live mentions Advance Next2 live mentions Generation Alzheimer2 live mentions Biomarker Assay Development2 live mentions Scientist Live Sino2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Sino Biological.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.